Background

• Multiple Sclerosis (MS) is a central nervous system demyelinating disease affecting approximately 2.8 million people worldwide1
• Research demonstrates that specialty pharmacists embedded in health system neurology clinics play an integral role in MS patient care by facilitating medication access, providing counseling, improving adherence and decreasing provider workload2,3,4
• A gap exists in current literature detailing types of pharmacist interventions and their acceptance rates in this patient population.

Objectives

Identify the types and outcomes of clinical interventions completed by health system specialty pharmacies (HSSP) for patients with MS.

Read the Outcomes Study by submitting the form below.

​